- Report
- May 2025
- 185 Pages
Global
From €3126EUR$3,545USD£2,697GBP
€3474EUR$3,939USD£2,996GBP
- Report
- April 2025
- 250 Pages
Global
From €3960EUR$4,490USD£3,416GBP
- Report
- July 2025
- 179 Pages
Global
From €5159EUR$5,850USD£4,450GBP
- Report
- April 2025
- 175 Pages
Global
From €3960EUR$4,490USD£3,416GBP
- Report
- May 2025
- 193 Pages
Global
From €3126EUR$3,545USD£2,697GBP
€3474EUR$3,939USD£2,996GBP
- Report
- May 2025
- 195 Pages
Global
From €3126EUR$3,545USD£2,697GBP
€3474EUR$3,939USD£2,996GBP
- Report
- May 2025
- 191 Pages
Global
From €3126EUR$3,545USD£2,697GBP
€3474EUR$3,939USD£2,996GBP
- Report
- August 2024
- 144 Pages
Global
From €2645EUR$2,999USD£2,281GBP
- Report
- October 2024
- 248 Pages
Global
From €3682EUR$4,175USD£3,176GBP
- Report
- November 2024
- 120 Pages
Global
From €5247EUR$5,950USD£4,526GBP
- Report
- February 2025
- 200 Pages
Global
From €3960EUR$4,490USD£3,416GBP
- Report
- April 2025
- 175 Pages
Global
From €3960EUR$4,490USD£3,416GBP
- Report
- April 2025
- 200 Pages
Global
From €3960EUR$4,490USD£3,416GBP
- Report
- July 2025
- 378 Pages
Global
From €5159EUR$5,850USD£4,450GBP
- Report
- February 2025
- 182 Pages
Global
From €3373EUR$3,825USD£2,910GBP
€3969EUR$4,500USD£3,423GBP
- Report
- February 2025
- 182 Pages
Global
From €3373EUR$3,825USD£2,910GBP
€3969EUR$4,500USD£3,423GBP
- Report
- January 2025
- 102 Pages
Global
From €3500EUR$4,251USD£3,125GBP
- Report
- August 2023
- 190 Pages
Global
From €4232EUR$4,799USD£3,651GBP
- Report
- July 2020
- 100 Pages
Global
From €3241EUR$3,675USD£2,796GBP
- Report
- May 2023
- 70 Pages
United States
From €5247EUR$5,950USD£4,526GBP

Plasma Therapy is a form of biopharmaceutical treatment that involves the use of plasma from a donor to treat a variety of medical conditions. Plasma is the liquid component of blood that contains proteins, antibodies, and other substances that can be used to treat a variety of diseases. Plasma Therapy is used to treat conditions such as hemophilia, immune deficiencies, and other autoimmune diseases. It is also used to treat certain types of cancer, as well as to reduce the risk of infection in patients with weakened immune systems.
Plasma Therapy is a relatively new form of biopharmaceutical treatment, and its use is increasing as more research is conducted into its potential benefits. It is a safe and effective form of treatment, and is often used in combination with other treatments to maximize its effectiveness.
Some companies in the Plasma Therapy market include CSL Behring, Grifols, Octapharma, Kedrion, and Biotest. Show Less Read more